(ANDE) The Andersons - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0341641035
Stock: Grain, Fertilizer, Ethanol, Biofuels
Total Rating 55
Risk 79
Buy Signal 0.17
| Risk 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Relative Tail Risk | -5.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.64 |
| Alpha | 58.17 |
| Character TTM | |
|---|---|
| Beta | 0.763 |
| Beta Downside | 1.894 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.94% |
| CAGR/Max DD | 0.54 |
EPS (Earnings per Share)
Revenue
Description: ANDE The Andersons March 04, 2026
The Andersons, Inc. (ANDE) is an agriculture and renewable fuels company. It operates in the United States, Canada, Mexico, and other international markets.
The companys Agribusiness segment focuses on commodity trading, including corn, wheat, and soybeans. This segment also manufactures and distributes agricultural fertilizers, a key input for crop production. The Renewables segment is involved in ethanol production and trading, a component of the biofuel industry.
For more in-depth analysis and data, ValueRay offers comprehensive research tools.
Headlines to watch out for
- Global grain prices impact agribusiness segment revenue
- Ethanol and biofuel demand affects Renewables segment
- Fertilizer input costs influence agricultural margins
- Weather patterns dictate crop yields and commodity supply
- International trade policies create market volatility
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 95.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -5.94 > 1.0 |
| NWC/Revenue: 6.27% < 20% (prev 9.94%; Δ -3.67% < -1%) |
| CFO/TA 0.05 > 3% & CFO 177.0m > Net Income 95.7m |
| Net Debt (944.7m) to EBITDA (309.1m): 3.06 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (34.2m) vs 12m ago -0.69% < -2% |
| Gross Margin: 6.33% > 18% (prev 0.06%; Δ 626.4% > 0.5%) |
| Asset Turnover: 281.0% > 50% (prev 273.2%; Δ 7.90% > 0%) |
| Interest Coverage Ratio: 3.45 > 6 (EBITDA TTM 309.1m / Interest Expense TTM 51.0m) |
Altman Z'' 2.89
| A: 0.19 (Total Current Assets 2.38b - Total Current Liabilities 1.69b) / Total Assets 3.71b |
| B: 0.28 (Retained Earnings 1.04b / Total Assets 3.71b) |
| C: 0.04 (EBIT TTM 175.7m / Avg Total Assets 3.92b) |
| D: 0.43 (Book Value of Equity 1.05b / Total Liabilities 2.42b) |
| Altman-Z'' Score: 2.89 = A |
Beneish M -3.13
| DSRI: 0.87 (Receivables 652.5m/764.5m, Revenue 11.01b/11.26b) |
| GMI: 0.99 (GM 6.33% / 6.28%) |
| AQI: 1.07 (AQ_t 0.08 / AQ_t-1 0.07) |
| SGI: 0.98 (Revenue 11.01b / 11.26b) |
| TATA: -0.02 (NI 95.7m - CFO 177.0m) / TA 3.71b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of ANDE shares?
As of March 16, 2026, the stock is trading at USD 70.74 with a total of 439,995 shares traded.
Over the past week, the price has changed by +7.65%, over one month by +5.57%, over three months by +26.01% and over the past year by +65.13%.
Over the past week, the price has changed by +7.65%, over one month by +5.57%, over three months by +26.01% and over the past year by +65.13%.
Is ANDE a buy, sell or hold?
The Andersons has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy ANDE.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ANDE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.3 | 3.7% |
| Analysts Target Price | 73.3 | 3.7% |
ANDE Fundamental Data Overview March 14, 2026
P/E Trailing = 25.3548
P/E Forward = 20.9205
P/S = 0.2177
P/B = 1.9404
P/EG = 0.8947
Revenue TTM = 11.01b USD
EBIT TTM = 175.7m USD
EBITDA TTM = 309.1m USD
Long Term Debt = 560.0m USD (from longTermDebt, last quarter)
Short Term Debt = 339.9m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 944.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.34b USD (2.40b + Debt 1.04b - CCE 98.3m)
Interest Coverage Ratio = 3.45 (Ebit TTM 175.7m / Interest Expense TTM 51.0m)
EV/FCF = -59.53x (Enterprise Value 3.34b / FCF TTM -56.1m)
FCF Yield = -1.68% (FCF TTM -56.1m / Enterprise Value 3.34b)
FCF Margin = -0.51% (FCF TTM -56.1m / Revenue TTM 11.01b)
Net Margin = 0.87% (Net Income TTM 95.7m / Revenue TTM 11.01b)
Gross Margin = 6.33% ((Revenue TTM 11.01b - Cost of Revenue TTM 10.31b) / Revenue TTM)
Gross Margin QoQ = 9.11% (prev 6.30%)
Tobins Q-Ratio = 0.90 (Enterprise Value 3.34b / Total Assets 3.71b)
Interest Expense / Debt = 1.33% (Interest Expense 13.8m / Debt 1.04b)
Taxrate = 18.82% (16.5m / 87.6m)
NOPAT = 142.7m (EBIT 175.7m * (1 - 18.82%))
Current Ratio = 1.41 (Total Current Assets 2.38b / Total Current Liabilities 1.69b)
Debt / Equity = 0.84 (Debt 1.04b / totalStockholderEquity, last quarter 1.24b)
Debt / EBITDA = 3.06 (Net Debt 944.7m / EBITDA 309.1m)
Debt / FCF = -16.83 (negative FCF - burning cash) (Net Debt 944.7m / FCF TTM -56.1m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 95.7m / Total Assets 3.71b)
RoE = 7.44% (Net Income TTM 95.7m / Total Stockholder Equity 1.29b)
RoCE = 9.52% (EBIT 175.7m / Capital Employed (Equity 1.29b + L.T.Debt 560.0m))
RoIC = 6.78% (NOPAT 142.7m / Invested Capital 2.10b)
WACC = 6.41% (E(2.40b)/V(3.44b) * Re(8.73%) + D(1.04b)/V(3.44b) * Rd(1.33%) * (1-Tc(0.19)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF] Fair Price = unknown (Cash Flow -56.1m)
EPS Correlation: 6.79 | EPS CAGR: 91.06% | SUE: 1.65 | # QB: 2
Revenue Correlation: -87.57 | Revenue CAGR: -11.31% | SUE: -1.67 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.17 | Chg7d=+0.000 | Chg30d=+0.320 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=4.78 | Chg7d=+0.000 | Chg30d=+0.378 | Revisions Net=+1 | Growth EPS=+48.1% | Growth Revenue=+5.2%
EPS next Year (2027-12-31): EPS=5.62 | Chg7d=+0.000 | Chg30d=+5.617 | Revisions Net=+0 | Growth EPS=+17.4% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.8% (Discount Rate 8.7% - Earnings Yield 3.9%)
[Growth] Growth Spread = -2.7% (Analyst 2.0% - Implied 4.8%)
P/E Forward = 20.9205
P/S = 0.2177
P/B = 1.9404
P/EG = 0.8947
Revenue TTM = 11.01b USD
EBIT TTM = 175.7m USD
EBITDA TTM = 309.1m USD
Long Term Debt = 560.0m USD (from longTermDebt, last quarter)
Short Term Debt = 339.9m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 944.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.34b USD (2.40b + Debt 1.04b - CCE 98.3m)
Interest Coverage Ratio = 3.45 (Ebit TTM 175.7m / Interest Expense TTM 51.0m)
EV/FCF = -59.53x (Enterprise Value 3.34b / FCF TTM -56.1m)
FCF Yield = -1.68% (FCF TTM -56.1m / Enterprise Value 3.34b)
FCF Margin = -0.51% (FCF TTM -56.1m / Revenue TTM 11.01b)
Net Margin = 0.87% (Net Income TTM 95.7m / Revenue TTM 11.01b)
Gross Margin = 6.33% ((Revenue TTM 11.01b - Cost of Revenue TTM 10.31b) / Revenue TTM)
Gross Margin QoQ = 9.11% (prev 6.30%)
Tobins Q-Ratio = 0.90 (Enterprise Value 3.34b / Total Assets 3.71b)
Interest Expense / Debt = 1.33% (Interest Expense 13.8m / Debt 1.04b)
Taxrate = 18.82% (16.5m / 87.6m)
NOPAT = 142.7m (EBIT 175.7m * (1 - 18.82%))
Current Ratio = 1.41 (Total Current Assets 2.38b / Total Current Liabilities 1.69b)
Debt / Equity = 0.84 (Debt 1.04b / totalStockholderEquity, last quarter 1.24b)
Debt / EBITDA = 3.06 (Net Debt 944.7m / EBITDA 309.1m)
Debt / FCF = -16.83 (negative FCF - burning cash) (Net Debt 944.7m / FCF TTM -56.1m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 95.7m / Total Assets 3.71b)
RoE = 7.44% (Net Income TTM 95.7m / Total Stockholder Equity 1.29b)
RoCE = 9.52% (EBIT 175.7m / Capital Employed (Equity 1.29b + L.T.Debt 560.0m))
RoIC = 6.78% (NOPAT 142.7m / Invested Capital 2.10b)
WACC = 6.41% (E(2.40b)/V(3.44b) * Re(8.73%) + D(1.04b)/V(3.44b) * Rd(1.33%) * (1-Tc(0.19)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF] Fair Price = unknown (Cash Flow -56.1m)
EPS Correlation: 6.79 | EPS CAGR: 91.06% | SUE: 1.65 | # QB: 2
Revenue Correlation: -87.57 | Revenue CAGR: -11.31% | SUE: -1.67 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.17 | Chg7d=+0.000 | Chg30d=+0.320 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=4.78 | Chg7d=+0.000 | Chg30d=+0.378 | Revisions Net=+1 | Growth EPS=+48.1% | Growth Revenue=+5.2%
EPS next Year (2027-12-31): EPS=5.62 | Chg7d=+0.000 | Chg30d=+5.617 | Revisions Net=+0 | Growth EPS=+17.4% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.8% (Discount Rate 8.7% - Earnings Yield 3.9%)
[Growth] Growth Spread = -2.7% (Analyst 2.0% - Implied 4.8%)